Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

BEYONDSPRING INC.

(BYSI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société BEYONDSPRING INC.
09/13BeyondSpring Presents New Clinical Evidence of Plinabulin Protection of Granulocyte-Mon..
AQ
08/29BeyondSpring Presents New Data for the Use of Plinabulin and Pegfilgrastim to Decrease ..
AQ
05/27BeyondSpring Presents New Clinical Data in the Chemotherapy-Induced Neutropenia and NSC..
AQ
04/28BeyondSpring Announces Three Poster Presentations at the American Society of Clinical O..
AQ
04/14BeyondSpring Files 2021 Annual Report on Form 20-F
AQ
04/14Beyondspring : Corporate Presentation
PU
04/14BeyondSpring Announces Fourth Quarter and Year End 2021 Financial Results and Provides ..
AQ
04/08BeyondSpring to Announce Fourth Quarter and Year End 2021 Financial Results and Host a ..
AQ
01/11Beyondspring : Announces Organizational Streamlining - Form 6-K
PU
01/11BeyondSpring Announces Organizational Streamlining
GL
01/03Beyondspring : Corporate Presentation
PU
2021Beyondspring : Announces Third Quarter 2021 Financial Results and Provides a Corporate Upd..
PU
2021BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Up..
GL
2021Beyondspring pharmaceuticals announces new clinical data confirming plinabulin's fast o..
AQ
2021BeyondSpring Pharmaceuticals Announces New Clinical Data Confirming Plinabulin's Fast O..
AQ
2021BeyondSpring Pharmaceuticals Announces Analysis of New Data on the Plinabulin/Pegfilgra..
GL
2021Beyondspring : Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabul..
PU
2021BeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabu..
AQ
2021Beyondspring : Corporate Presentation
PU
2021BeyondSpring Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Confe..
GL
2021BeyondSpring Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Confe..
GL
2021BeyondSpring Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Confere..
GL
2021BeyondSpring Appoints Commercial Leader Mark Santos to its Board of Directors - Form 6-..
PU
2021BeyondSpring Appoints Commercial Leader Mark Santos to its Board of Directors
AQ
2021Beyondspring : Announces First Patient Treated in Phase 2 Study with Plinabulin Combined w..
AQ
2021Beyondspring : Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabu..
AQ
2021Beyondspring : Pharmaceuticals Announces Positive Final Phase 3 DUBLIN-3 Data with the Pli..
PU
2021Beyondspring : Dublin-3 (bpi-2358-103)
PU
2021Beyondspring : Pharmaceuticals Announces Positive Final Phase 3 DUBLIN-3 Data with the Pli..
AQ
2021Beyondspring : Pharmaceuticals Announces New Positive Data on Plinabulin from Its Chemothe..
AQ
2021Beyondspring : Corporate Presentation
PU
2021Beyondspring : Announces Second Quarter 2021 Financial Results and Provides a Corporate Up..
AQ
2021Beyondspring : Announces Three Poster Presentations About its Chemotherapy-Induced Neutrop..
AQ
2021BeyondSpring to Participate in the Upcoming September Conferences
GL
2021Beyondspring : to Host Second Quarter Financial Results and Corporate Update Conference Ca..
AQ
2021Beyondspring : Announces Late-Breaking Oral Presentation of Final Phase 3 DUBLIN-3 Data wi..
AQ
2021Beyondspring : Announces Exclusive Commercialization and Co-development Agreement with Jia..
PU
2021Beyondspring : Announces Exclusive Commercialization and Co-development Agreement with Jia..
AQ
2021Beyondspring : CEO Dr. Lan Huang Named to PharmaVOICE 100 Most Inspiring People in Life Sc..
AQ
2021Beyondspring : DUBLIN-3 Topline Data
PU
2021Beyondspring : Announces Positive Topline Results from its DUBLIN-3 Registrational Trial o..
AQ
2021Beyondspring : Strengthens Board with the Addition of Ex-Immunomedics and Constellation Co..
PU
2021BeyondSpring Strengthens Board with the Addition of Ex-Immunomedics and Constellation C..
GL
2021Beyondspring : to Participate in the William Blair Biotech Focus Conference
AQ
2021BeyondSpring to Host R&D Day to Discuss Novel Immune Agent Plinabulin's Development Pro..
GL
2021Beyondspring : TD Ameritrade Watch List
PU
2021Beyondspring : 2021 First Quarter Financial Report
PU
2021Beyondspring : Announces First Quarter 2021 Financial Results and Provides a Corporate Upd..
PU
2021Beyondspring : Announces First Quarter 2021 Financial Results and Provides a Corporate Upd..
AQ
2021BeyondSpring to Host First Quarter Financial Results and Corporate Update Conference Ca..
GL
2021BeyondSpring Announces Final Positive Data from the PROTECTIVE-1 Phase 3 CIN Program of..
GL
2021Beyondspring : Announces a Late-Breaking Poster Presentation of PROTECTIVE-2 Phase 3 Data ..
AQ
2021Beyondspring : Announces Three Presentations Highlighting Positive Clinical Outcome Data f..
AQ
2021BeyondSpring Announces First Patient Dosed in a Triple Combination Study with Plinabuli..
GL
2021Beyondspring : Corporate Presentation
PU
2021BeyondSpring Announces U.S. FDA Acceptance and Priority Review of New Drug Application ..
GL
2021Beyondspring : to Present at the Jefferies Virtual Healthcare Conference on June 3, 2021
AQ
2021BeyondSpring Presents Phase 1 Data on the Anti-Cancer Effect of Plinabulin in Combinati..
GL
2021BeyondSpring to Present at the Bank of America Securities 2021 Health Care Conference o..
GL
2021Beyondspring : Corporate Presentation
PU
2021Beyondspring : Files 2020 Annual Report on Form 20-F
AQ
2021Beyondspring : Announces Fourth Quarter and Year End 2020 Financial Results and Provides a..
AQ
2021BeyondSpring Announces Five Presentations at the American Society of Clinical Oncology ..
GL
2021Beyondspring : to Announce Fourth Quarter and Year End 2020 Financial Results and Host a C..
AQ
2021BeyondSpring to Announce Fourth Quarter and Year End 2020 Financial Results and Host a ..
GL
2021BeyondSpring Announces Submission of New Drug Application to U.S. FDA and China NMPA fo..
GL
2021Beyondspring : Managing Chemotherapy Toxicities for Improved Patient Outcomes
PU
2021Beyondspring : Amendment to Current Report by Foreign Issuer (SEC Filing - 6-K/A)
PU
2021BeyondSpring Hosting Key Opinion Leader Webinar on Plinabulin for the Prevention of Che..
GL
2020UPDATE -- BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 1..
GL
2020BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021
GL
2020BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors
GL
2020BeyondSpring to Present at Two Upcoming Scientific Conferences in December
GL
2020Beyondspring : to Participate in Upcoming Evercore ISI 2020 Conference
PU
2020BeyondSpring to Participate in Upcoming Evercore ISI 2020 Conference
GL
1  2  3Next
Upcoming event on BEYONDSPRING INC.